NEW YORK (GenomeWeb News) – Invitrogen will use BioMicro Systems’ microarray user interface hybridization system with its new NCode miRNA profiling platform, the companies said last week.
 
The companies will co-market BioMicro’s system, called MAUI, with the NCode arrays. 
 
Invitrogen said “preliminary data” shows that using the MAUI system with the NCode arrays results in a 10-fold gain in sensitivity over manual hybridization.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.